| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenues | $0 | $0 | $0-100.0% | $38K+63459.3% | $59-90.8% | $643 |
| Selling, general and administrative expenses | $2.0M+20.2% | $1.7M-9.6% | $1.8M-16.8% | $2.2M-92.6% | $29.6M+102.4% | $14.6M |
| Research and development expenses | $270K-24.2% | $356K-40.6% | $599K-4.1% | $625K+163.0% | $237K-3.2% | $245K |
| Total Operating Expenses | $2.3M+12.3% | $2.0M-17.3% | $2.4M-14.0% | $2.8M-90.5% | $29.8M+100.7% | $14.8M |
| Loss from Operations | -$2.3M-12.3% | -$2.0M+17.3% | -$2.4M+13.4% | -$2.8M+90.6% | -$29.8M-100.7% | -$14.8M |
| Interest expense | -$113K-250.5% | -$32K+20.2% | -$41K-138.0% | -$17K+92.5% | -$226K-7.7% | -$210K |
| Interest expense - related party | -$87K-13.0% | -$77K-1.6% | -$76K-22.4% | -$62K+84.2% | -$392K-16.6% | -$336K |
| Gain (loss) on derivative liabilities | $28K | $0 | — | — | — | — |
| Fraud loss | -$242K | $0 | — | — | — | — |
| Gain (loss) on settlement of debt | $0-100.0% | $115K+242.9% | -$81K+61.6% | -$210K+51.8% | -$435K-37.3% | -$317K |
| Total Other Income (Expense) | -$414K-7188.1% | $6K+103.0% | -$197K-117.7% | $1.1M+248.9% | -$749K+13.2% | -$863K |
| Income tax expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Loss | -$2.7M-33.4% | -$2.0M+23.7% | -$2.6M-55.5% | -$1.7M+94.5% | -$30.5M-94.4% | -$15.7M |
| Basic and diluted | -$0.01+0.0% | -$0.01+0.0% | -$0.01+0.0% | -$0.01+92.9% | -$0.14-55.6% | -$0.09 |
| Weighted average number of shares outstanding | 257.0M+3.5% | 248.2M+3.8% | 239.1M+4.1% | 229.7M+1.8% | 225.7M+22.8% | 183.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.